An anti-interleukin-1 (anti-IL-1) alpha antibody called MABp1 has been shown to significantly improve response in patients with metastatic colorectal cancer (mCRC) in a phase III clinical trial that adopted symptom control as criteria for objective response (OR).
Regorafenib significantly improves overall survival (OS) and progression-free survival (PFS) in patients with intermediate or advanced hepatocellular carcinoma (HCC) whose disease progressed on sorafenib treatment, according to results of the phase III RESOURCE trial presented at the European Society for Medical Oncology (ESMO) 18th World Congress on Gastrointestinal Cancer.
Asia's trusted medical magazine for healthcare professionals.
Get your MIMS Pharmacist - Malaysia digital copy today!
Taking long-chain omega-3 fatty acids (LC-OM3) supplements, mainly EPA* and DHA** omega-3s, was associated with a modest but significant reduction in cardiac death risk, according to a meta-analysis of randomized controlled trials (RCTs).
Copper intrauterine device exhibited superior efficacy to injectable progestin contraception in women attending termination of pregnancy services in South Africa, according to a pragmatic, open-label, parallel arm, randomised controlled trial.